POST-CONTRAST ACUTE KIDNEY INJURY AND CONTRAST-INDUCED NEPHROPATHY IN ADULTS 42
45. de Geus HR, Betjes MG, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future
challenges. Clinical kidney journal 2012;5:102-08.
46. Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for kidney injury biomarker evaluation. Journal of the American
Society of Nephrology : JASN 2012;23:13-21.
47. Ostermann M, Bellomo R, Burdmann EA, et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improvin g Global
Outcomes (KDIGO) Conference. Kidney international 2020;98:294-309.
48. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum
creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine 1999;130:461-70.
49. Davenport MS, Khalatbari S, Cohan RH, Ellis JH. Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of
serum creatinine level- and estimated glomerular filtration rate-based screening methods. Radiology 2013;269:92-100.
50. Herts BR, Schneider E, Poggio ED, Obuchowski NA, Baker ME. Identifying outpatients with renal insufficiency before contrast -enhanced CT by
using estimated glomerular filtration rates versus serum creatinine levels. Radiology 2008;248:106-13.
51. Karlsberg RP, Dohad SY, Sheng R. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of
iodinated contrast medium. Journal of vascular and interventional radiology : JVIR 2011;22:1159-65.
52. Nyman U, Almén T, Jacobsson B, Aspelin P. Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?
European radiology 2012;22:1366-71.
53. Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA. Background fluctuation of kidney function versus contrast -induced
nephrotoxicity. AJR Am J Roentgenol 2009;192:711-8.
54. Cramer BC, Parfrey PS, Hutchinson TA, et al. Renal function following infusion of radiologic contrast material. A prospective controlled study.
Archives of internal medicine 1985;145:87-9.
55. Heller CA, Knapp J, Halliday J, O'Connell D, Heller RF. Failure to demonstrate contrast nephrotoxicity. The Medical journal of Australia
1991;155:329-32.
56. Langner S, Stumpe S, Kirsch M, Petrik M, Hosten N. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of
the brain with a nonionic, dimeric, iso-osmolal contrast medium. AJNR. American journal of neuroradiology 2008;29:1525-9.
57. Lima FO, Lev MH, Levy RA, et al. Functional Contrast-Enhanced CT for Evaluation of Acute Ischemic Stroke Does Not Increase the Risk of
Contrast-Induced Nephropathy. American Journal of Neuroradiology 2010;31:817-21.
58. McGillicuddy EA, Schuster KM, Kaplan LJ, et al. Contrast-induced nephropathy in elderly trauma patients. The Journal of trauma 2010;68:294-
7.
59. Oleinik A, Romero JM, Schwab K, et al. CT angiography for intracerebral hemorrhage does not increase risk of acute nephropath y. Stroke
2009;40:2393-7.
60. Tremblay LN, Tien H, Hamilton P, et al. Risk and benefit of intravenous contrast in trauma patients with an elevated serum creatinine. The
Journal of trauma 2005;59:1162-6; discussion 66-7.
61. Media ACoDaC. ACR Manual on Contrast Media. https://www.acr.org/Clinical-Resources/Contrast-Manual. Accessed April 22, 2021.
62. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both.
A prospective controlled study. The New England journal of medicine 1989;320:143-9.
63. Abujudeh HH, Gee MS, Kaewlai R. In emergency situations, should serum creatinine be checked in all patients before performing second
contrast CT examinations within 24 hours? Journal of the American College of Radiology : JACR 2009;6:268-73.
64. Trivedi H, Foley WD. Contrast-induced nephropathy after a second contrast exposure. Renal failure 2010;32:796-801.
65. Stacul F, Bertolotto M, Thomsen HS, et al. Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and
ESUR Contrast Media Safety Committee guidelines. European radiology 2018;28:683-91.
66. Pahade JK, LeBedis CA, Raptopoulos VD, et al. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing
contrast-enhanced CT. AJR Am J Roentgenol 2011;196:1094-101.
67. Crowley MP, Prabhakaran VN, Gilligan OM. Incidence of Contrast-Induced Nephropathy in Patients with Multiple Myeloma Undergoing
Contrast-Enhanced Procedures. Pathology oncology research : POR 2018;24:915-19.
68. Kim SM, Cha RH, Lee JP, et al. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a
quality improvement report. American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;55:1018-25.
69. Thomsen HS, Morcos SK. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two
randomized trials. European radiology 2009;19:891-7.
70. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ. Incidence and outcomes of contrast-induced AKI following computed
tomography. Clinical journal of the American Society of Nephrology : CJASN 2008;3:1274-81.
71. Nyman U, Ahlkvist J, Aspelin P, et al. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR
guidelines. European radiology 2018;28:5384-95.
72. Too CW, Ng WY, Tan CC, Mahmood MI, Tay KH. Screening for impaired renal function in outpatients before iodinated contrast injection:
Comparing the Choyke questionnaire with a rapid point-of-care-test. European journal of radiology 2015;84:1227-31.
73. Choyke PL, Cady J, DePollar SL, Austin H. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?
Techniques in urology 1998;4:65-9.
74. Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA. Are screening serum creatinine levels necessary prior to outpatient CT
examinations? Radiology 2000;216:481-4.
75. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and
information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical
care (London, England) 2004;8:R204-12.
76. Lakhal K, Ehrmann S, Chaari A, et al. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and
outcome. Journal of critical care 2011;26:593-9.
77. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. American journal of kidney diseases : the official journal of the National
Kidney Foundation 2002;39:930-6.
78. Valette X, Parienti JJ, Plaud B, Lehoux P, Samba D, Hanouz JL. Incidence, morbidity, and mortality of contrast -induced acute kidney injury in a
surgical intensive care unit: a prospective cohort study. Journal of critical care 2012;27:322.e1-5.